Circulating HPV DNA for early detection of minimal residual disease after definitive therapy in oropharyngeal cancer: A phase II biomarker-driven study.
Authors
Luana Guimarães de Sousa (ORCID: https://orcid.org/0000-0002-3516-7105)
Amy C. Moreno (ORCID: https://orcid.org/0000-0001-6762-6807)
Jeffrey Myers
Neal Akhave
Van K. Morris
Maura L. Gillison
Xiuning Le
Robyn Du
J. Jack Lee
Renata Ferrarotto
Institutions
The University of Texas MD Anderson Cancer Center (US)
Circulating HPV DNA for early detection of minimal residual disease after definitive therapy in oropharyngeal cancer: A phase II biomarker-driven study.
Luana Guimarães de Sousa, Amy C. Moreno, Jeffrey Myers, Neal Akhave et al.
Journal
Journal of Clinical Oncology
Topics
Head and Neck Cancer Studies
article
Circulating HPV DNA for early detection of minimal residual disease after definitive therapy in oropharyngeal cancer: A phase II biomarker-driven study.
Luana Guimarães de Sousa, Amy C. Moreno, Jeffrey Myers, Neal Akhave, Van K. Morris, Maura L. Gillison, Xiuning Le, Robyn Du, J. Jack Lee, Renata Ferrarotto
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical OncologyVol. 44(16_suppl)
Institutions
The University of Texas MD Anderson Cancer Center (US)